Page last updated: 2024-08-23

fosinopril and quinapril

fosinopril has been researched along with quinapril in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (38.46)18.2507
2000's5 (38.46)29.6817
2010's3 (23.08)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karlberg, BE; Olsson, AG; Wuttge, DM; Ziedén, B1
Evans, BL; Pylypchuk, GB; Sharif, MN1
Binder, SB1
Benzie, IF; Tomlinson, B1
Akarawut, W; Lin, CJ; Smith, DE1
Bicket, DP1
Pfützner, W; Przybilla, B; Ruëff, F1
Chou, J; Debanne, SM; Fang, JC; Mishra, P; Simon, DI; Sipahi, I1
Abbenante, G; Fairlie, DP; Leung, D1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

5 review(s) available for fosinopril and quinapril

ArticleYear
ACE inhibitors: review of four new agents.
    American family physician, 1993, Volume: 48, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Fosinopril; Heart Failure; Humans; Hypertension; Isoquinolines; Quinapril; Ramipril; Tetrahydroisoquinolines

1993
Using ACE inhibitors appropriately.
    American family physician, 2002, Aug-01, Volume: 66, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States

2002
Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk.
    The American journal of cardiology, 2011, Jul-15, Volume: 108, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Enalapril; Fosinopril; Humans; Lisinopril; Neoplasms; Quinapril; Ramipril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines

2011
Protease inhibitors: current status and future prospects.
    Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3

    Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors

2000
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for fosinopril and quinapril

ArticleYear
Effects of in vitro addition of captopril on copper-induced low density lipoprotein oxidation.
    British journal of clinical pharmacology, 1995, Volume: 39, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Copper; Ethanol; Fosinopril; Humans; In Vitro Techniques; Isoquinolines; Lipoproteins, LDL; Oxidation-Reduction; Quinapril; Tetrahydroisoquinolines

1995
Cough induced by quinapril with resolution after changing to fosinopril.
    The Annals of pharmacotherapy, 1994, Volume: 28, Issue:6

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cough; Female; Fosinopril; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines

1994
Antioxidant power of angiotensin-converting enzyme inhibitors in vitro.
    British journal of clinical pharmacology, 1998, Volume: 45, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Captopril; Colorimetry; Dose-Response Relationship, Drug; Enalapril; Ferric Compounds; Ferrous Compounds; Fosinopril; Indoles; Isoquinolines; Oxidation-Reduction; Perindopril; Quinapril; Tetrahydroisoquinolines

1998
Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
    Pharmaceutical research, 1999, Volume: 16, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding, Competitive; Captopril; Carrier Proteins; Cell Membrane; Dipeptides; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Isoquinolines; Kidney; Kinetics; Lipid Metabolism; Lipids; Lisinopril; Male; Microvilli; Peptide Transporter 1; Quinapril; Rabbits; Ramipril; Symporters; Tetrahydroisoquinolines

1999
Systemic contact dermatitis due to captopril without cross-sensitivity to fosinopril, quinapril and benazepril.
    Acta dermato-venereologica, 2004, Volume: 84, Issue:1

    Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Dermatitis, Contact; Female; Fosinopril; Humans; Hypertension; Quinapril; Skin Tests; Tetrahydroisoquinolines

2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008